Situation in the Region of the Americas
On 23 July 2022, the WHO Director-General declared the multi-country outbreak of monkeypox constitutes a Public Health Emergency of International Concern (PHEIC). Access the dashboard for daily reported cases, the weekly situation report, and epidemiological alerts and updates to stay up-to-date with the situation in the Region of the Americas.
PAHO's response
The Pan American Health Organization / World Health Organization (PAHO/WHO) supports the Member States with surveillance, preparedness, and outbreak response activities for monkeypox in affected countries.
Given the occurrence of cases of monkeypox in countries within and outside of the Region of the Americas, PAHO activated its standard emergency procedures (SEPs) and established an incident management team with the active participation of personnel from over 15 entities of PAHO/HQ to ensure a timely response to the outbreak and lead preparedness efforts in the Member States. Moreover, WHO is working to improve access to a vaccine that was developed for smallpox (MVA-BN, also known as Imvamune, Imvanex, or Jynneos) which was approved in 2019 for use in preventing monkeypox and is not yet widely available.
Based on the epidemiological situation and evidence from Europe, the response is currently focused on four main pillars.
Response pillars:
1.
Communication and engagement of at-risk communities.
2.
Timely detection and treatment of patients and protection of health workers.
3.
Laboratory confirmation, surveillance, and containment of transmission chains.
4.
Securing access to critical health supplies.
Response Strategy and Donor Alert
An estimated US$1,284,000 is needed for the initial 3-month response plan to stem further transmission of monkeypox and mitigate the impact of the outbreak in the Americas.
PAHO and its strategic partners throughout the Region, using a whole-of-society approach have launched a Response Strategy and Donor Alert to continue supporting Latin American and Caribbean countries.
Donations will enable us to:
Ensure evidence-based information is communicated appropriately and that communities are engaged to prevent infection, and combat misinformation.
Ensure that the Member States have installed capacities to timely detect and contain the spread of Monkeypox.
Treat and protect health workers, ensuring that the Member States receive evidence-based guidance and appropriate tools to manage cases of Monkeypox adequately.
Provide leadership, coordination, and logistical support for the emergency response phase of the MPX epidemics in the Region.
Information on monkeypox changes rapidly as more data becomes available.
For the most up-to-date information visit this website frequently.
News
Events
21 Jun 2022 - 21 Jun 2022
